Economic analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction: Results from EPHESUS

被引：0
|
作者：
Weintraub, WS
Zhang, Z
Mahoney, EM
Spertus, J
Tooley, J
Akhras, K
Willke, R
Pitt, B
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Mid Amer Heart Inst, Kansas City, MO USA
[3] Pfizer, New York, NY USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1603
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [41] Biomarkers of prognosis in patients with post-acute-myocardial infarction heart failure: results of an EPHESUS sub-study
    Ketelslegers, J
    Schiffrin, EL
    Williams, G
    Garthwaite, S
    He, W
    Patni, R
    Pitts, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 582 - 582
  • [42] Is eplerenone a cost-effective therapy for heart failure patients after myocardial infarction?
    Dickstein, K
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (09): : 440 - 441
  • [43] Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial
    Ferreira, Joao Pedro
    Rossello, Xavier
    Pitt, Bertram
    Rossignol, Patrick
    Zannad, Faiez
    CLINICAL CARDIOLOGY, 2019, 42 (11) : 1106 - 1112
  • [44] How early should eplerenone be initiated in acute myocardial infarction complicated by heart failure? An analysis of early vs. late initiation in the EPHESUS trial
    Zannad, F.
    Adamopoulos, C.
    Fay, R.
    Ahmed, A.
    Filippatos, G.
    Pitt, B.
    EUROPEAN HEART JOURNAL, 2007, 28 : 52 - 52
  • [45] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
    Susan Stienen
    Patrick Rossignol
    António Barros
    Nicolas Girerd
    Bertram Pitt
    Faiez Zannad
    João Pedro Ferreira
    Clinical Research in Cardiology, 2020, 109 : 194 - 204
  • [46] Hyperglycemia and Poor Outcomes in Patients without Diabetes Mellitus in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS): A Propensity Matched Analysis
    Deedwania, Prakash C.
    Pitt, Bertram
    Carbajal, Enrique V.
    Ahmed, Ali
    CIRCULATION, 2008, 118 (18) : S583 - S583
  • [47] Statin therapy and clinical outcomes in acute heart failure patients complicating acute myocardial infarction: insights from the EPHESUS trial
    Dobre, D.
    Rossignol, P.
    Murin, Y.
    Parkhomenko, A.
    Lamiral, Z.
    Krum, H.
    Van Veldhuisen, D. J.
    Pitt, B.
    Zannad, F.
    EUROPEAN HEART JOURNAL, 2012, 33 : 807 - 808
  • [48] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
    Stienen, Susan
    Rossignol, Patrick
    Barros, Antonio
    Girerd, Nicolas
    Pitt, Bertram
    Zannad, Faiez
    Ferreira, Joao Pedro
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (02) : 194 - 204
  • [49] Relation of loop diuretic dose to morbimortality in patients with heart failure and left ventricular systolic dysfunction: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)
    Tala, S.
    Rossignol, P.
    Fay, R.
    Pitt, B.
    Zannad, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 2 - 2
  • [50] Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective
    Thomas D. Szucs
    Majbrit V. Holm
    Matthias Schwenkglenks
    Zefeng Zhang
    William S. Weintraub
    Michel Burnier
    Paul Erne
    Cardiovascular Drugs and Therapy, 2006, 20 : 193 - 204
12345